; The mission of the Developmental Core (Core B) is to foster and support innovative, interdisciplinaiy research into the pathogenesis, prevention and treatment of HIV/AIDS by Penn CFAR investigators;enhance the cadre of investigators studying HIV/AIDS by providing support and leadership for emerging investigators and facilitating entry into the field by researchers in other areas;and encourage and support innovative research in scientific priorities areas identified through CFAR strategic planning. In order to achieve these goals, the Developmental Core carries out three Specific Aims: (1) a Pilot Grant awards program that funds up to 6 developmental grants each year, evaluated through a rigorous peer review process for scientific merit and concordance with the mission of the Developmental Core and scientific priorities of the CFAR;(2) a Mentoring program to provide advice, support and leadership for the next generation of investigators to facilitate their transition into independent research careers in HIV/AIDS, and;(3) a series of workshops, working groups and outreach activities designed to bring together investigators from different but potentially interrelated areas to foster interdisciplinary interactions. In the 14 years since the Penn CFAR's inception (FY2000-2013), the Developmental Core has supported 77 pilot projects that have resulted in significant new knowledge of HIV/AIDS: supported the development of research priorities identified through the CFAR strategic planning process: served as the springboard to independent research careers of junior scientists: and led to subsequent funding of multiple research grants from NIH and other sources with an investment of $2.9M in pilot funding and a total of $55 million in new funding, for a 19 to 1 return on investment in developmental funding support. In the coming cycle, the Developmental Core will continue with its successful pilot grant program, will enhance our junior investigator mentoring program, and continue to serve as a vehicle for realizing priorities and initiatives critical for the interactive research program on campus.

Public Health Relevance

;Core B's mission is to promote innovative research into the pathogenesis, prevention and treatment of HIV/AIDS, support the development of the next generation of researchers, and foster research focused on CFAR key scientific priorities. To achieve these goals, the Core will: 1) mentor Junior investigators and bring investigators in other fields into HIV research, 2) promote new collaborative initiatives among CFAR investigators, and 3) provide seed funds to accomplish these goals through a pilot grant funding program.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI045008-16
Application #
8697208
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
16
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Salantes, D Brenda; Zheng, Yu; Mampe, Felicity et al. (2018) HIV-1 latent reservoir size and diversity are stable following brief treatment interruption. J Clin Invest 128:3102-3115
Hogan, Michael J; Conde-Motter, Angela; Jordan, Andrea P O et al. (2018) Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization. Virology 514:106-117
Tawe, Leabaneng; Grover, Surbhi; Narasimhamurthy, Mohan et al. (2018) Molecular detection of human papillomavirus (HPV) in highly fragmented DNA from cervical cancer biopsies using double-nested PCR. MethodsX 5:569-578
Lazar, Nellie Riendeau; Salas-Humara, Caroline; Wood, Sarah M et al. (2018) Missed Opportunities for HIV Screening Among a Cohort of Adolescents With Recently Diagnosed HIV Infection in a Large Pediatric Hospital Care Network. J Adolesc Health 63:799-802
Gowda, Charitha; Lott, Stephen; Grigorian, Matthew et al. (2018) Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study. Open Forum Infect Dis 5:ofy076
Krump, Nathan A; Liu, Wei; You, Jianxin (2018) Mechanisms of persistence by small DNA tumor viruses. Curr Opin Virol 32:71-79
Coviello, D M; Lovato, R; Apostol, K et al. (2018) Prevalence of HIV Viral Load Suppression Among Psychiatric Inpatients with Comorbid Substance Use Disorders. Community Ment Health J :
Clarke, Erik L; Connell, A Jesse; Six, Emmanuelle et al. (2018) T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency. Genome Med 10:70
Martei, Yehoda M; Pace, Lydia E; Brock, Jane E et al. (2018) Breast Cancer in Low- and Middle-Income Countries: Why We Need Pathology Capability to Solve This Challenge. Clin Lab Med 38:161-173
Ojikutu, Bisola O; Bogart, Laura M; Higgins-Biddle, Molly et al. (2018) Facilitators and Barriers to Pre-Exposure Prophylaxis (PrEP) Use Among Black Individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC). AIDS Behav 22:3576-3587

Showing the most recent 10 out of 775 publications